NCT07034222: 12-Month Real-World Safety & Efficacy of Lecanemab in Early Alzheimer's Disease
- State
- Under way
- Phase
- Phase 4
- People
- 80 planned
- Started
- 1 Feb 2024
- Primary completion
- 1 Jan 2026
- Arms
- Lecanemab treatment group
- Results
- None posted
- 1 Feb 2024: Trial started
- 24 Jun 2025: Trial registered